Skip to main content
. 2021 Oct 9;41(1):175–179. doi: 10.1007/s10096-021-04350-y

Table 3.

Results from all cerebrospinal fluid samples combined, analysed with the ReaScan CXCL13 assay and the recomBead CXCL13 assay, n = 209

LNB (n = 69)1 Non-LNB (n = 140)2 Sensitivity Specificity
ReaScan CXCL13
  Positive 54 7
  Negative 15 133 78% 95%
recomBead CXCL13
  Positive 59 13
  Negative 10 127 86% 91%

LNB Lyme neuroborreliosis. 1The LNB group comprised both definite LNB and patients with short symptom duration; probable early LNB. 2The non-LNB group included patients both with and without cerebrospinal fluid pleocytosis